Lipodox

Description

Lipodox  is a microencapsulated cytostatic drug, the molecules of the active substance (doxorubicin hydrochloride) are enclosed in a liposomal microcapsule. The drug is available in the form of a lyophilized powder for the preparation of a solution for intravenous injection. One bottle contains 0.01 g of doxorubicin hydrochloride. The mechanism of the antitumor effect of the drug is based on the intercalation of cellular DNA and the effect on the membrane of tumor cells. The drug is highly active against a large number of tumors of various locations, as well as leukemia. It has low cardiotoxicity (due to the low concentration of the drug in the myocardium), less pronounced myelo- and immunosuppressive effects than the free form of doxorubicin, and has a prolonged effect due to the slow release of doxorubicin through the liposome shell.

Indicated for the treatment of soft tissue sarcomas and osteogenic sarcomas, breast cancer, lung cancer, thyroid cancer, mesothelioma, malignant thymoma, cancer of the esophagus, stomach, liver, biliary tract, pancreas, hepatocellular cancer, kidney cancer, body and cervix, Williams tumor , Ewing’s sarcoma, neuroblastoma, embryonal rhabdomyosarcoma, prostate cancer, acute leukemia, myeloma, lymphogranulomatosis, non-Hodgkin’s lymphoma, especially in cases of resistant forms.

Active ingredient: Doxorubicin

Prescription medicine